drugset / Trial / NCT06528444

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

NCT06528444 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical trial with an active ingredient of a pharmaceutical specialty marketed in Spain vs. placebo. Randomized, double-blind, multicenter phase III clinical trial that evaluates the efficacy and safety of dexamethasone compared to placebo in patients with severe influenza.

Timeline

Start
2024-10-01
Primary completion
2028-10-31
Completion
2028-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 6 mg —

Indications